Effects of a checkpoint kinase inhibitor, AZD7762, on tumor suppression and bone remodelingLuqi Wang(Harbin Medical University), Hiroki Yokota(Harbin Medical University)International Journal of OncologyJuly 13, 201810.3892/ijo.2018.4481Cited by 20SaveCiteExport RISWatch citationsRelated PapersSuppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1/moesin-mediated inhibition of TGFβ/FN1/CD44 signaling|Theranostics|2021|67